Genscript Biotech Corp (GNNSF)
1.47
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Genscript Biotech Total Liabilities (Quarterly): 1.343B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.343B |
| June 30, 2023 | 1.298B |
| June 30, 2023 | 1.298B |
| December 31, 2022 | 1.184B |
| June 30, 2022 | 1.256B |
| June 30, 2022 | 1.256B |
| December 31, 2021 | 846.18M |
| June 30, 2021 | 728.71M |
| June 30, 2021 | 728.71M |
| December 31, 2020 | 315.38M |
| June 30, 2020 | 554.36M |
| June 30, 2020 | 554.36M |
| December 31, 2019 | 517.11M |
| Date | Value |
|---|---|
| June 30, 2019 | 422.95M |
| June 30, 2019 | 422.95M |
| December 31, 2018 | 423.68M |
| June 30, 2018 | 393.23M |
| June 30, 2018 | 393.23M |
| December 31, 2017 | 275.94M |
| June 30, 2017 | 41.60M |
| June 30, 2017 | 41.60M |
| December 31, 2016 | 42.01M |
| June 30, 2016 | 37.75M |
| June 30, 2016 | 37.75M |
| December 31, 2015 | 32.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
315.38M
Minimum
Dec 2020
1.343B
Maximum
Dec 2023
848.39M
Average
728.71M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.387B |
| Shareholders Equity (Quarterly) | 1.391B |
| Debt to Equity Ratio | 0.2474 |
| Current Ratio | 4.756 |
| Net Debt Paydown Yield | -0.95% |